Atlas Trials

Metastatic Bladder Urothelial Carcinoma

17 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Metastatic Bladder Urothelial Carcinoma

RecordFirmDate
Testing Combination Erdafitinib and Enfortumab Vedotin in Metastatic Bladder Cancer After Treatment With Chemotherapy and Immunotherapy (NCT04963153)National Cancer Institute (NCI)2022-07-07
Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study (NCT05092958)National Cancer Institute (NCI)2022-06-03
Trying to Find the Correct Length of Treatment With Immune Checkpoint Therapy (NCT04637594)Alliance for Clinical Trials in Oncology2022-05-27
Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma (NCT04940299)M.D. Anderson Cancer Center2021-09-23
Comparing the New Anti-cancer Drug Eribulin With Chemotherapy Against the Usual Chemotherapy Alone in Metastatic Urothelial Cancer (NCT04579224)National Cancer Institute (NCI)2021-06-28
Immune Checkpoint Inhibitors With or Without Propranolol Hydrochloride In Patients With Urothelial Carcinoma (NCT04848519)Emory University2021-05-20
Adoptive Cell Therapy With (LN-145) in Combination With Pembrolizumab in Treating Patients With Unresectable or Metastatic Transitional Cell Cancer Who Have Failed Cisplatin-Based Chemotherapy (NCT03935347)Roswell Park Cancer Institute2019-06-20
Atezolizumab and CYT107 in Treating Participants With Locally Advanced, Inoperable, or Metastatic Urothelial Carcinoma (NCT03513952)National Cancer Institute (NCI)2019-06-05
Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or Prostate (NCT03582475)Jonsson Comprehensive Cancer Center2019-01-11
Atezolizumab With or Without Eribulin Mesylate in Treating Patients With Recurrent Locally Advanced or Metastatic Urothelial Cancer (NCT03237780)National Cancer Institute (NCI)2018-07-20
Cisplatin and Gemcitabine Hydrochloride With or Without Berzosertib in Treating Patients With Metastatic Urothelial Cancer (NCT02567409)National Cancer Institute (NCI)2017-01-31
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer (NCT00942331)National Cancer Institute (NCI)2009-07-15

Track Metastatic Bladder Urothelial Carcinoma automatically

Every clearance here is in the API, with alerts when new ones post.